In EGPA, 30–40% of patients are ANCA-positive, and mostly have a perinuclear fluorescence-labelling pattern (P-ANCA) with anti-myeloperoxidase (MPO) specificity. Here, MPO is linked to eosinophilic granulomatosis with polyangiitis.